Can animals develop depression? An overview and assessment of ‘depression-like’ states

Behaviour ◽  
2021 ◽  
pp. 1-51
Author(s):  
Aileen MacLellan ◽  
Carole Fureix ◽  
Andrea Polanco ◽  
Georgia Mason

Abstract Describing certain animal behaviours as ‘depression-like’ or ‘depressive’ has become common across several fields of research. These typically involve unusually low activity or unresponsiveness and/or reduced interest in pleasure (anhedonia). While the term ‘depression-like’ carefully avoids directly claiming that animals are depressed, this narrative review asks whether stronger conclusions can be legitimate, with animals developing the clinical disorder as seen in humans (cf., DSM-V/ICD-10). Here, we examine evidence from animal models of depression (especially chronically stressed rats) and animals experiencing poor welfare in conventional captive conditions (e.g., laboratory mice and production pigs in barren environments). We find troubling evidence that animals are indeed capable of experiencing clinical depression, but demonstrate that a true diagnosis has yet to be confirmed in any case. We thus highlight the importance of investigating the co-occurrence of depressive criteria and discuss the potential welfare and ethical implications of animal depression.

2020 ◽  
Vol 77 (1) ◽  
pp. 29-36
Author(s):  
Patrick Köck ◽  
Johannes Strasser
Keyword(s):  
Dsm V ◽  

Zusammenfassung. Die Indikation zur Durchführung einer Opioid-Agonisten-Therapie (OAT) ist einfach gestellt und orientiert sich einzig am Vorliegen eines Opioidabhängigkeitsyndroms gemäss ICD 10 (oder DSM-V). Für den Behandlungserfolg ist eine adäquate, individuelle Dosierung des Opioid-Agonisten entscheidend. Es stehen mehrere als gleichwertig zu betrachtende Opioide mit unterschiedlichen Nebenwirkungsprofilen zur Verfügung. Komorbide Erkrankungen sind häufig und haben Einfluss auf Lebensqualität sowie das Suchtverhalten. Sie sollten deshalb für die Behandlungsplanung und -umsetzung berücksichtigt und idealerweise ebenfalls behandelt werden. Im folgenden Artikel wird der State-Of-The-Art der OAT dargestellt, mit Fokus auf den deutschsprachigen Raum Europas. Er soll einen Überblick über Diagnostik, Behandlungsoptionen, Medikamente sowie spezifische Herausforderungen der OAT geben. Die Empfehlungen orientieren sich vorwiegend am Schweizer Modell. Somit muss die Behandlungsdurchführung gemäss der jeweiligen Landesgesetzgebung entsprechend modifiziert werden.


Sensors ◽  
2019 ◽  
Vol 19 (5) ◽  
pp. 1165 ◽  
Author(s):  
Andrew Hamilton ◽  
Chris Davison ◽  
Christos Tachtatzis ◽  
Ivan Andonovic ◽  
Craig Michie ◽  
...  

The reticuloruminal function is central to the digestive efficiency in ruminants. For cattle, collar- and ear tag-based accelerometer monitors have been developed to assess the time spent ruminating on an individual animal. Cattle that are ill feed less and so ruminate less, thus, the estimation of the time spent ruminating provides insights into the health of individual animals. pH boluses directly provide information on the reticuloruminal function within the rumen and extended (three hours or more) periods during which the ruminal pH value remains below 5.6 is an indicator that dysfunction and poor welfare are likely. Accelerometers, incorporated into the pH boluses, have been used to indicate changes in behaviour patterns (high/low activity), utilised to detect the onset of oestrus. The paper demonstrates for the first time that by processing the reticuloruminal motion, it is possible to recover rumination periods. Reticuloruminal motion energy and the time between reticuloruminal contractions are used as inputs to a Support Vector Machine (SVM) to identify rumination periods with an overall accuracy of 86.1%, corroborated by neck mounted rumination collars.


2021 ◽  
Vol 22 (3) ◽  
pp. 1047
Author(s):  
Dorsa Rafiei ◽  
Nathan J. Kolla

Altered activity of fatty acid amide hydrolase (FAAH), an enzyme of the endocannabinoid system, has been implicated in several neuropsychiatric disorders, including major depressive disorder (MDD). It is speculated that increased brain FAAH expression is correlated with increased depressive symptoms. The aim of this scoping review was to establish the role of FAAH expression in animal models of depression to determine the translational potential of targeting FAAH in clinical studies. A literature search employing multiple databases was performed; all original articles that assessed FAAH expression in animal models of depression were considered. Of the 216 articles that were screened for eligibility, 24 articles met inclusion criteria and were included in this review. Three key findings emerged: (1) FAAH expression is significantly increased in depressive-like phenotypes; (2) genetic knockout or pharmacological inhibition of FAAH effectively reduces depressive-like behavior, with a dose-dependent effect; and (3) differences in FAAH expression in depressive-like phenotypes were largely localized to animal prefrontal cortex, hippocampus and striatum. We conclude, based on the animal literature, that a positive relationship can be established between brain FAAH level and expression of depressive symptoms. In summary, we suggest that FAAH is a tractable target for developing novel pharmacotherapies for MDD.


2015 ◽  
Vol 9s1 ◽  
pp. JEN.S32735
Author(s):  
Darryl J. Mayeaux ◽  
Sarah M. Tandle ◽  
Sean M. Cilano ◽  
Matthew J. Fitzharris

In animal models of depression, depression is defined as performance on a learning task. That task is typically escaping a mild electric shock in a shuttle cage by moving from one side of the cage to the other. Ovarian hormones influence learning in other kinds of tasks, and these hormones are associated with depressive symptoms in humans. The role of these hormones in shuttle-cage escape learning, however, is less clear. This study manipulated estradiol and progesterone in ovariectomized female rats to examine their performance in shuttle-cage escape learning without intentionally inducing a depressive-like state. Progesterone, not estradiol, within four hours of testing affected latencies to escape. The improvement produced by progesterone was in the decision to act, not in the speed of learning or speed of escaping. This parallels depression in humans in that depressed people are slower in volition, in their decisions to take action.


2005 ◽  
Vol 29 (4-5) ◽  
pp. 515-523 ◽  
Author(s):  
Alan Frazer ◽  
David A. Morilak

2009 ◽  
Vol 96 (2) ◽  
pp. 209-217 ◽  
Author(s):  
Y. Braw ◽  
O. Malkesman ◽  
A. Merenlender ◽  
M. Dagan ◽  
A. Bercovich ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document